English:Aging – Deubiquitylases, redox state and causal identification
aiMOOCAging – Deubiquitylases, redox state and causal identification
QR-Code
Introduction
This expert colloquium examines how to reason from molecular measurements to causal claims in aging, with a focus on deubiquitylases (DUBs), redox-sensitive catalytic cysteines, ubiquitin signaling, and the aging brain. The central case study is the 2026 Nature Communications paper by Sahu and colleagues, Oxidative stress causes a reversible decrease of deubiquitylases activity in old vertebrate brains. You will audit what the experiments establish, what they only suggest, and what additional evidence would be needed before using strong language such as "rejuvenation".
The course is designed for advanced university learners, doctoral researchers, postdoctoral scientists, and professionals in molecular neuroscience, proteostasis, chemical biology, redox biology, or geroscience. You should be comfortable with experimental design, protein biochemistry, basic statistics, and causal inference.
A guiding principle for the entire colloquium is this: DUB abundance, catalytic activity, and activity-based-probe binding are related but non-identical observables. A second principle is that normalization of molecular markers is not by itself evidence that an aged brain has been functionally rejuvenated. Stronger claims require convergent mechanistic, synaptic, physiological, and organism-level evidence.
Biological Background
The ubiquitin system and deubiquitylases
Ubiquitin is a small protein modifier that can be attached to protein substrates through an E1-E2-E3 enzymatic cascade. Different ubiquitin-chain linkages can encode different fates, including proteasomal degradation, trafficking, DNA-repair signaling, and other regulatory outcomes. DUBs remove ubiquitin from substrates or edit ubiquitin chains. Most human DUBs are cysteine proteases; a smaller group are metalloproteases.
The term DUB activity must be operationalized carefully. At least three quantities can diverge:
- Protein abundance: how much DUB protein is present.
- Catalytic activity: how rapidly the enzyme hydrolyzes an appropriate ubiquitin substrate under specified conditions.
- Probe reactivity: how strongly an activity-based probe labels or enriches the enzyme under specified chemistry and sample-processing conditions.
An activity-based ubiquitin probe usually contains a ubiquitin recognition element, a reactive warhead, and a reporter or affinity handle. Covalent capture often depends on a nucleophilic catalytic cysteine, but probe labeling is still a chemical reaction with its own kinetics and selectivity. Therefore, reduced labeling should not automatically be equated with reduced physiological catalysis. Reviews of ubiquitin activity-based probes explicitly caution that some probes can label non-catalytic cysteines or non-DUB proteins; "probe-reactive" can be a safer description until catalysis is verified independently.
Proteasomes and proteostasis
The proteasome degrades many ubiquitin-tagged proteins and is a central component of cellular proteostasis. In aging research, a mechanistic question is whether altered ubiquitin editing by DUBs occurs upstream of proteasome impairment, downstream of it, or in a feedback loop.
.svg)
Temporal precedence is useful but not sufficient for causality. If event A occurs before event B, A may contribute to B, but a third process could drive both. Causal identification becomes stronger when temporal ordering is combined with targeted perturbation, dose-response evidence, orthogonal readouts, and rescue.
Redox chemistry and catalytic cysteines
A catalytic cysteine can cycle among chemically distinct states. A reduced thiol or thiolate can be oxidized to sulfenic acid and, depending on context, can form disulfides, mixed disulfides, sulfenamides, or more oxidized species. Some modifications are reversible; others are harder or impossible to reverse under physiological conditions.
This matters because oxidation can simultaneously alter enzyme catalysis and probe capture. A probe that requires attack by a reduced catalytic cysteine may lose signal when the cysteine is oxidized even if the protein remains present. Conversely, a redox-targeting probe can be designed to capture oxidized forms such as DUB-SOH. Thus, redox state is not merely a nuisance variable; it can be part of the mechanism and also part of the measurement process.
Reduced glutathione, oxidized glutathione, total free thiols, NRF2 abundance, and direct cysteine-oxidation measurements answer different questions. A shift in one does not guarantee a shift in all others.
Audit of Sahu et al. 2026
The primary paper is openly accessible: Sahu et al. 2026, Nature Communications.
What the study measured
Sahu and colleagues used activity-based proteomics and biochemical assays in aging mouse and killifish brains, together with human iPSC-derived neurons. In mouse brain, the probe workflow pooled three ubiquitin-based electrophilic probes: Biotin-Ahx-Ub-VME, Biotin-Ahx-Ub-PA, and Biotin-Ahx-Ub-VS. N-ethylmaleimide served as a sulfhydryl-blocking control. The study also used a fluorescent DUB substrate assay, proteome measurements, thiol measurements, proteasome activity assays, ubiquitylome profiling, pharmacological DUB inhibition, USP7 inhibition, ex vivo reduction with DTT, and in vivo antioxidant treatment with NACET.
The paper reported that many DUBs lost probe-defined activity with age without corresponding loss of total protein abundance. In mouse brain, 20 of 27 DUBs with age-associated activity changes in at least one cohort showed no significant abundance change by the study's stated thresholds. In killifish, 5 of 6 DUBs with reduced activity did not show a corresponding abundance decrease, with USP25 as an exception. This is important evidence that abundance alone does not explain the observed age effect.
The abundance-activity-probe distinction
A rigorous audit should assign every result to the quantity it actually measures.
| Question | Primary observable | What it supports | Main caveat |
|---|---|---|---|
| Is less DUB protein present? | Total proteomics or immunoblot abundance | Change in protein amount | Does not reveal catalytic competence |
| Does a DUB hydrolyze substrate more slowly? | Independent substrate cleavage kinetics | Catalytic impairment | Substrate choice and assay conditions matter |
| Does a ubiquitin probe enrich less DUB? | Probe labeling or enrichment | Reduced probe reactivity under that chemistry | Can reflect oxidation, steric effects, accessibility, non-catalytic labeling, or competition |
| Is the catalytic cysteine more oxidized? | Site-resolved redox proteomics or oxidation-state probe | Direct redox modification | Sample handling can create or erase redox states |
A strong interpretation therefore requires an explicit chain: stable abundance plus lower probe reactivity plus lower orthogonal catalytic activity plus direct evidence of catalytic-cysteine oxidation. Each link constrains a different alternative explanation.
Temporal ordering
The longitudinal age comparison reported a stable reduced-thiol concentration through 12 months followed by a significant decrease beginning at 18 months. DUB activity also declined after 18 months, while a significant decrease in proteasome chymotrypsin-like activity emerged only after 24 months. This supports the proposition that DUB impairment can appear earlier than the measured proteasome impairment.
However, temporal order alone does not establish that DUB decline causes proteasome decline. Both could be consequences of an upstream redox or metabolic process. The paper strengthened the causal case by adding perturbation experiments in neurons.
Broad DUB inhibition as intervention evidence
In human iPSC-derived neurons, acute DUB inhibition with PR619 for 6 hours did not alter proteasome activity in the reported experiment. By contrast, 24-hour exposure to 7.5 micromolar PR619 increased ubiquitylated proteins, increased K48-linked polyubiquitin, and reduced proteasome activity, whereas 5 micromolar did not show the same effect. This creates a temporal and dose-dependent perturbation pattern consistent with chronic DUB impairment contributing to proteasome dysfunction.
The causal interpretation remains bounded because PR619 is a broad DUB inhibitor. It does not identify which DUBs are necessary or sufficient, and off-target or stress effects remain plausible. A broad inhibitor is therefore stronger evidence for the role of the DUB system than for any single DUB.
USP7 as a targeted case
The study selected USP7 because its age-associated activity decrease was among the strongest. Twenty-four-hour P5091 treatment of differentiated iNeurons altered the ubiquitylome and partially recapitulated age-associated ubiquitylation patterns. Some overlapping proteins were involved in proteostasis, cytoskeletal organization, trafficking, synaptic transmission, and ion-channel regulation.
This is useful perturbation evidence, but it should not be overinterpreted. P5091 is a first-generation compound that has also been reported to inhibit the related DUB USP47. Later USP7 inhibitors such as FT671 and FT827 were developed with substantially improved specificity in tested DUB panels. Therefore, a causal claim specifically assigning the phenotype to USP7 should include chemical and genetic cross-checks.
Redox reversal and NACET rescue
The paper used DTT ex vivo to test whether reducing conditions could restore DUB probe reactivity or activity, supporting reversible thiol oxidation as a mechanism. In vivo, aged female mice treated with NACET for 12 days showed increased reduced-thiol availability, restored DUB activity, lower K48-linked polyubiquitin, and enhanced proteasome activity. The treatment did not significantly increase GSH in that experiment.
These findings demonstrate biochemical reversibility of several age-associated molecular phenotypes. They do not by themselves establish rejuvenation of synaptic physiology, cognition, behavior, network function, or whole-organism performance. The authors explicitly noted that downstream physiological and behavioral consequences remained to be systematically explored.
Causal Evidence Ladder
A useful way to evaluate mechanistic claims is to ask which rungs of a causal ladder are satisfied.
- Association: age covaries with lower DUB probe reactivity or catalytic activity.
- Separation of observables: activity changes are distinguished from protein abundance and probe chemistry.
- Temporal precedence: the candidate cause changes before the downstream phenotype.
- Perturbation: inhibiting the candidate process moves the downstream phenotype in the predicted direction.
- Specificity: orthogonal perturbations that share the same target but not the same off-target profile reproduce the effect.
- Rescue: restoring the relevant target or biochemical state reverses the phenotype.
- Genetic epistasis: target-specific genetic manipulation changes the response to the pharmacological or redox perturbation.
- Functional transfer: molecular rescue propagates to synaptic, physiological, and behavioral endpoints.
- Durability: the effect persists beyond the immediate treatment window and is not explained by acute stress compensation.
A single experiment rarely satisfies all levels. Causal confidence emerges from convergence.
Orthogonal USP7 Test Design
Chemical cross-check
A decisive USP7 experiment should not rely on P5091 alone. Use at least two chemically distinct USP7 perturbations with validated target-engagement profiles. One strategy is to compare P5091 with a more selective inhibitor such as FT671. The expected logic is not "both drugs change the same marker, therefore USP7 is causal"; rather, concordant effects across structurally distinct compounds reduce the probability that a shared phenotype is caused by unrelated off-target chemistry.
Measure direct USP7 target engagement, total USP7 abundance, USP7 catalytic activity using a substrate-cleavage assay, and the relevant site-specific ubiquitylation changes. Include a DUB-wide activity profile to verify that the selective inhibitor does not reproduce the broad suppression caused by PR619.
Genetic cross-check
Use CRISPR interference, inducible knockdown, or another validated loss-of-function approach to reduce USP7 without using a small molecule. Then perform rescue with an expression construct resistant to the genetic perturbation.
A particularly informative rescue compares:
- Wild-type USP7: restores USP7 protein and catalytic activity.
- Catalytically inactive USP7 C223S: restores protein abundance but not the catalytic nucleophile.
If wild-type USP7 rescues the molecular and functional phenotype but C223S does not, the evidence points toward catalytic activity rather than a purely structural or scaffolding role. Expression levels should be matched to avoid supraphysiological rescue artifacts.
Specificity logic
The chemical and genetic experiments should be factorial rather than sequential anecdotes. An example matrix includes control, selective USP7 inhibitor, USP7 knockdown, inhibitor plus knockdown, wild-type rescue, and C223S rescue. If an inhibitor still produces the full phenotype in cells where USP7 is already strongly depleted, that argues for a substantial USP7-independent component.
A complementary test is to perturb USP47 directly. Because P5091 has reported activity against USP47, USP47 knockdown or selective discrimination by a newer USP7 inhibitor helps determine whether the P5091 phenotype is misassigned.
Orthogonal Redox-Artifact Test Design
Why the artifact problem matters
The catalytic cysteine that makes many DUBs redox sensitive is also the nucleophile used by common ubiquitin electrophile probes. Therefore, oxidation can lower probe capture even when the total DUB protein is unchanged. If sample preparation changes the cysteine state, an apparent biological age effect can be amplified, reduced, or even created ex vivo.
Four independent redox checks
- Redox proteomics: directly quantify oxidation state at the catalytic cysteine, using immediate thiol blocking and isotope-coded differential labeling or another site-resolved method.
- Orthogonal activity assay: measure cleavage of a fluorogenic ubiquitin substrate or defined ubiquitin-chain substrate under controlled conditions rather than relying only on covalent probe capture.
- Oxidized-state probe: add a chemistry that can capture sulfenylated DUBs, such as a validated DUB-SOH-directed ubiquitin probe, so that loss of reduced-state probe signal is paired with gain of an oxidized-state signal.
- Ex vivo rescue and process control: test whether DTT or TCEP restores catalysis while using rapid quenching, matched processing time, oxygen exposure controls, and spike-in standards to distinguish biological oxidation from handling artifacts.
A strong redox mechanism predicts reciprocal behavior: reduced-state DUB activity falls, catalytic-cysteine oxidation rises, reducing treatment restores activity within the reversible window, and total protein abundance remains stable.
Sample-handling controls
Redox measurements demand stricter handling than ordinary proteomics. Predefine tissue harvest time, temperature, delay to quench, buffer composition, pH, metal chelation, and oxygen exposure. Block free thiols as early as possible in a dedicated aliquot. Do not infer native oxidation state from a sample that was first incubated with a reducing agent.
Include a common reference lysate or isotopically labeled internal standard across batches. Randomize age and treatment groups across extraction and mass-spectrometry runs. Blind sample identity during signal extraction where possible.
From Molecular Rescue to Rejuvenation
Synaptic endpoints are mandatory for a brain-function claim
The Sahu study identified age-sensitive ubiquitylation changes in proteins involved in synaptic signaling, including proteins associated with vesicle fusion and ion-channel regulation. These molecular annotations are not the same as demonstrating restored synaptic function.
For a claim that redox-DUB rescue improves neuronal function, include endpoints such as:
- Long-term potentiation or another pre-specified plasticity assay in hippocampal slices.
- Miniature postsynaptic current frequency and amplitude to separate presynaptic and postsynaptic effects.
- Synaptic vesicle release or recycling using an orthogonal optical or electrophysiological assay.
- Dendritic spine density and morphology as a structural endpoint, interpreted alongside physiology rather than instead of it.
- Network-level activity or synchrony where relevant to the model.
A convincing study should show that the same intervention that normalizes the molecular DUB-redox axis also improves at least one direct synaptic physiological endpoint.
Organism-level functional endpoints
For an aged-mouse study, pre-specified behavioral or systems-level outcomes should be chosen for mechanistic relevance and interpreted with controls for locomotion, vision, anxiety, motivation, and general health. Depending on the hypothesis, useful endpoints could include object-recognition memory, spatial alternation, contextual memory, sensory function, or motor performance.
Behavioral testing should be blinded, randomized, adequately powered, and separated from biochemical analysis where possible. A drug that changes exploration or activity can create apparent memory effects without improving memory itself.
Minimum standard for a rejuvenation claim
A strong "rejuvenation" claim should require more than movement of biomarkers toward a young mean. At minimum, specify before the experiment:
- Molecular target engagement showing that the intended DUB-redox mechanism was changed.
- A direct catalytic readout separated from probe binding and protein abundance.
- A synaptic or cellular physiological endpoint that is impaired with age and improves with treatment.
- An organism-level functional endpoint that is impaired with age and improves without a major performance confound.
- Genetic or orthogonal pharmacological evidence linking the functional improvement to the proposed mechanism.
- Evidence that the effect is not merely acute toxicity, sedation, hyperactivity, or a generalized stress response.
- A durability assessment after washout or at a later time point.
If only thiols, DUB activity, K48 chains, or proteasome activity normalize, the defensible conclusion is biochemical or proteostatic rescue, not brain rejuvenation.
Experimental Blueprint for a Definitive Follow-up
Aim 1: Separate abundance, catalysis, and probe binding
Collect young and aged mouse brain tissue under redox-preserving conditions. Quantify total DUB abundance by proteomics and immunoblotting. In parallel aliquots, perform reduced-state ubiquitin probe profiling, direct substrate-cleavage assays, and catalytic-cysteine redox proteomics. Analyze USP7 and the broader DUB panel.
The key prediction is a four-way separation: stable total USP7 abundance, lower catalytic activity, lower reduced-state probe reactivity, and higher catalytic-cysteine oxidation in aged tissue.
Aim 2: Test causal sufficiency and necessity of USP7 impairment
In human iPSC-derived neurons or primary neuronal cultures, compare vehicle, P5091, a selective USP7 inhibitor such as FT671, USP7 CRISPR interference, and matched rescue with wild-type or C223S USP7. Add a USP47 perturbation arm to test a major first-generation inhibitor confound.
Read out USP7 target engagement, DUB-wide activity, ubiquitylome changes, proteasome activity, cell health, and synaptic function. Concordance between selective chemical inhibition and genetic depletion, together with wild-type but not C223S rescue, would materially strengthen a USP7-catalysis claim.
Aim 3: Test redox causality without relying on one antioxidant
Compare NACET with a mechanistically distinct redox manipulation and with direct genetic modulation of the antioxidant system where feasible. Measure actual catalytic-cysteine oxidation rather than only global thiols. Determine whether molecular rescue persists when antioxidant treatment is stopped.
To separate "redox restores DUBs" from "redox independently helps proteasomes", include a condition in which USP7 or a broader DUB set remains genetically impaired during antioxidant treatment. If antioxidant rescue of proteasome and synaptic endpoints disappears when the critical DUB activity cannot be restored, that is epistasis evidence for mediation through the DUB axis.
Aim 4: Require synaptic and functional rescue
In aged animals, pair biochemical endpoints with hippocampal synaptic physiology and a pre-registered behavioral endpoint. Sample sizes should be justified from the functional primary endpoint, not from a large molecular effect measured in a small pilot.
A particularly informative analysis tests mediation: treatment changes redox state, redox state changes DUB catalytic activity, DUB activity changes synaptic physiology, and synaptic physiology predicts behavioral improvement. Mediation analysis cannot prove the full biological chain by itself, but it can organize evidence when combined with intervention and genetic epistasis.
Interpreting Negative and Discordant Results
Discordance is scientifically useful.
If probe binding decreases with age but direct catalytic cleavage does not, suspect probe chemistry, accessibility, or sample-handling effects. If catalysis decreases but total protein abundance also decreases, a redox-specific mechanism is not necessary to explain the effect. If NACET restores DUB activity but synaptic physiology remains impaired, the DUB-redox axis may be biochemically reversible without being sufficient for neuronal functional restoration. If FT671 and USP7 CRISPR interference disagree with P5091, reassess off-target effects, exposure, compensatory adaptation, and USP47.
If wild-type USP7 and C223S both rescue a phenotype, a non-catalytic or scaffolding function becomes plausible. If neither rescues, the phenotype may not be USP7-dependent, the rescue level may be incorrect, or broader DUB-network impairment may dominate.
Common Causal Errors to Avoid
- Correlation does not imply causation: age-associated co-variation is not a perturbation experiment.
- Temporal precedence: earlier change strengthens directionality but does not eliminate common causes.
- Pharmacological specificity: one inhibitor is not a genetic identity test.
- Activity-based probe: probe reactivity is not automatically equivalent to physiological turnover.
- Rescue experiment: broad antioxidant rescue can act at multiple nodes and therefore is not automatically target-specific.
- Biomarker: movement toward a young molecular profile is not synonymous with restoration of young function.
- Mechanistic inference: pathway enrichment among ubiquitylated proteins does not demonstrate altered pathway output.
Interactive Tasks
Quiz: Test Your Knowledge
Which measurement directly addresses how much DUB protein is present? (Total protein abundance) (!Activity probe enrichment) (!Fluorogenic substrate turnover) (!Behavioral performance)
Why can reduced ubiquitin probe labeling be ambiguous? (Probe chemistry can change independently of protein abundance) (!Every probe measures protein abundance only) (!Probe labeling cannot involve cysteine chemistry) (!All DUBs are metalloproteases)
What temporal pattern was reported in aging mouse brain? (DUB decline appeared before significant proteasome decline) (!Proteasome decline appeared before DUB decline) (!Both changed only in young mice) (!Neither changed with age)
What does chronic PR619 treatment mainly test? (The consequence of broad DUB inhibition) (!The exclusive role of USP7) (!The abundance of glutathione) (!The structure of the proteasome)
Why is P5091 insufficient as the only USP7 perturbation? (It can also affect USP47) (!It increases USP7 abundance only) (!It is a proteasome subunit) (!It is a redox buffer)
Which genetic rescue best tests whether USP7 catalysis is required? (Wild type rescue compared with C223S rescue) (!Two vehicle controls) (!One extra proteomics run) (!A larger imaging field)
What is the key purpose of a DUB SOH probe? (To detect an oxidized DUB cysteine state) (!To measure mouse behavior) (!To count proteasome particles) (!To quantify RNA abundance)
What did short NACET treatment in aged mice establish most directly? (Biochemical reversibility of several age associated molecular changes) (!Complete rejuvenation of brain function) (!Permanent restoration of memory) (!Elimination of all oxidative stress)
Which endpoint is most directly synaptic and functional? (Long term potentiation) (!Total USP7 abundance) (!Global thiol concentration) (!K48 chain abundance)
What is required before calling a molecular rescue brain rejuvenation? (Convergent molecular synaptic and organism level functional evidence) (!A single normalized biomarker) (!One significant proteomics pathway) (!A larger probe signal)
Memory Game
| DUB abundance | Amount of deubiquitylase protein present |
| Catalytic activity | Rate of ubiquitin substrate hydrolysis |
| Probe reactivity | Chemical capture by an activity based probe |
| Temporal precedence | Candidate cause changes before downstream outcome |
| Genetic rescue | Reintroduction of a target to test causality |
| Epistasis | Testing whether one intervention depends on another pathway component |
| Synaptic physiology | Direct functional measurement of neuronal communication |
| Redox proteomics | Site resolved measurement of oxidation state |
Drag and Drop
| Match the correct terms. | Topic |
|---|---|
| Total proteomics | DUB protein amount |
| Substrate cleavage | Catalytic turnover |
| Ubiquitin probe | Probe reactivity |
| Cysteine redox proteomics | Oxidation state |
| Electrophysiology | Synaptic function |
...
Crossword Puzzle
| Ubiquitin | What protein modifier is edited by DUBs? |
| Cysteine | Which amino acid commonly provides the catalytic nucleophile in cysteine protease DUBs? |
| Proteasome | Which complex degrades many polyubiquitylated proteins? |
| NACET | Which antioxidant intervention was used in aged mice in the Sahu study? |
| Synapse | Where should neuronal functional rescue be demonstrated before a brain rejuvenation claim? |
| Rescue | What experiment reverses a perturbation to strengthen causal inference? |
LearningApps
Cloze Text
Open-Ended Tasks
Easy
- Evidence map: Build a one-page diagram that separates DUB abundance, catalytic activity, probe binding, redox state, proteasome activity, synaptic physiology, and behavior; label each arrow as measured, inferred, or untested.
- Figure audit: Choose one figure from Sahu et al. 2026 and write a short caption that states exactly what was measured without using the words cause, restore, or rejuvenate unless the design justifies them.
- Probe chemistry: Produce an annotated image or short video explaining why oxidation of a catalytic cysteine can change activity-based-probe capture without changing protein abundance.
- Endpoint hierarchy: Create a table that classifies ten candidate endpoints as molecular, catalytic, synaptic, systems-level, or behavioral and explain which are required for a functional brain claim.
Standard
- USP7 inhibitor comparison: Compare P5091 with FT671 or FT827 using primary literature, and propose a two-compound experiment that can distinguish USP7 target effects from first-generation inhibitor off-target effects.
- Redox handling protocol: Draft a sample-processing standard operating procedure that minimizes ex vivo oxidation and includes early thiol blocking, randomization, reference standards, and blinded analysis.
- Synaptic rescue study: Design a slice-electrophysiology experiment in aged mice that tests whether NACET improves long-term potentiation and specify the biochemical measurements collected from matched tissue.
- Research interview: Interview a researcher in proteomics, neuroscience, or redox biology about one common source of causal overinterpretation and compare their answer with the evidence ladder used in this course.
Advanced
- Factorial causality experiment: Design a factorial experiment combining selective USP7 inhibition, USP7 CRISPR interference, wild-type rescue, C223S rescue, and USP47 perturbation; pre-specify predictions for each outcome pattern.
- Redox epistasis: Propose a genetic intervention that prevents restoration of a candidate DUB during antioxidant treatment and explain how the result would support or weaken a DUB-mediated redox mechanism.
- Rejuvenation preregistration: Write a preregistered analysis plan for an aged-mouse intervention in which a rejuvenation claim is allowed only if molecular, synaptic, and organism-level primary endpoints meet pre-specified criteria.
- Replication project: Design a multi-laboratory replication that separates tissue processing, mass-spectrometry acquisition, electrophysiology, and behavioral testing across blinded teams while preserving a common causal analysis plan.
Learning Assessment
- Causal graph assessment: Draw a directed acyclic graph linking age, redox state, DUB oxidation, DUB catalysis, probe binding, ubiquitin-chain accumulation, proteasome activity, synaptic physiology, and behavior; identify at least three confounders or alternative pathways.
- Evidence weighting assessment: Explain why temporal precedence, broad inhibition, selective inhibition, genetic rescue, and functional rescue provide different kinds of causal information rather than interchangeable repetitions.
- USP7 inference assessment: Given concordant P5091 and aging ubiquitylome signatures but discordant FT671 and CRISPR results, propose at least three explanations and the next experiment that distinguishes them.
- Redox artifact assessment: Interpret a dataset in which aged tissue shows lower Ub-VME labeling but unchanged substrate cleavage and no increase in catalytic-cysteine oxidation; state which original claim is no longer supported.
- Rejuvenation threshold assessment: Evaluate a hypothetical NACET experiment that normalizes thiols, DUB activity, and K48 chains but leaves LTP and memory unchanged; write the strongest defensible conclusion.
- Transfer assessment: Apply the abundance-activity-probe framework to another cysteine enzyme system and explain which orthogonal measurements would be needed before making a catalytic claim.
Evidence of Learning
- Knowledge: You can distinguish DUB abundance, catalytic activity, probe reactivity, cysteine oxidation, proteasome activity, synaptic physiology, and organism-level function.
- Methodological skill: You can identify which assay measures which construct and detect when one observable is being used as a surrogate for another without validation.
- Causal reasoning: You can combine temporal order, perturbation, specificity, rescue, and epistasis without treating any single element as decisive.
- Experimental design: You can build orthogonal USP7 and redox-artifact tests with chemical and genetic cross-checks.
- Scientific communication: You can write conclusions whose strength matches the actual endpoint hierarchy and avoid equating biochemical normalization with rejuvenation.
- Research product: You can produce a preregistered follow-up study that includes molecular, synaptic, and functional primary endpoints.
- Transfer achievement: You can apply the same causal audit to other aging mechanisms, activity-based probes, redox-sensitive enzymes, or pharmacological rescue claims.
OERs on the Topic
Primary and open-access resources for deeper study:
- Sahu et al. 2026: Oxidative stress causes a reversible decrease of deubiquitylases activity in old vertebrate brains
- Activity-based probes for the ubiquitin conjugation-deconjugation machinery
- Activity-Based Ubiquitin Probes for Investigation of Deubiquitinases
- Deubiquitinases as a signaling target of oxidative stress
- Activity-Based Ubiquitin Probes Capture the Sulfenylated State of Deubiquitinases
- Molecular basis of USP7 inhibition by selective small molecule inhibitors
- The basics of thiols and cysteines in redox biology and chemistry
- HHMI BioInteractive: Ubiquitin and the Proteasome
Linked Learning Areas